Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2872477 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
Surgical treatment of MSPLC is safe and effective. TNM stage I, tumor size 2 cm or less, or less than 20 pack-years smoking are predictors of improved survival. Sublobar resection is acceptable. For stage I disease, lobectomy tends to be associated with better survival than sublobar resection, although the difference is not significant, and completion pneumonectomy is not recommended. Long-term follow-up is necessary even after curative resection of lung cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jie MD, Ming MD, Jie MD, Nan MD, Wen-xin MD, Yu-ling MD, Yan MD, Ge-ning MD,